Rosiglitazone in Treating Patients With Pituitary Tumors

Clinical trial NCT00616642 · TERMINATED

Trial details

NCT number: NCT00616642
Sponsor: Jonsson Comprehensive Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2006-10-01
Primary completion: 2010-11-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.